| stem cell differentiation | GO:0048863 | 268 | 0.202 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.193 | Mouse |
| lipid homeostasis | GO:0055088 | 63 | 0.191 | |
| epidermis development | GO:0008544 | 187 | 0.188 | |
| regulation of cell motility | GO:2000145 | 236 | 0.165 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.161 | |
| male gamete generation | GO:0048232 | 285 | 0.155 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.142 | |
| oogenesis | GO:0048477 | 56 | 0.132 | |
| digestive tract development | GO:0048565 | 190 | 0.126 | |
| germ cell development | GO:0007281 | 185 | 0.125 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.114 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.110 | |
| spermatogenesis | GO:0007283 | 284 | 0.106 | |
| forebrain cell migration | GO:0021885 | 58 | 0.101 | |
| action potential | GO:0001508 | 78 | 0.097 | |
| gastrulation | GO:0007369 | 116 | 0.096 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.095 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.094 | Mouse |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.094 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.094 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.090 | |
| ear morphogenesis | GO:0042471 | 118 | 0.088 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.088 | |
| cation transport | GO:0006812 | 399 | 0.085 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.084 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.083 | |
| response to radiation | GO:0009314 | 165 | 0.083 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.082 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.082 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.079 | |
| organelle fission | GO:0048285 | 170 | 0.078 | |
| urogenital system development | GO:0001655 | 261 | 0.077 | |
| epithelial cell development | GO:0002064 | 159 | 0.076 | |
| blastocyst development | GO:0001824 | 80 | 0.075 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.073 | |
| axonogenesis | GO:0007409 | 274 | 0.072 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.072 | |
| cell division | GO:0051301 | 120 | 0.071 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.070 | |
| protein localization to organelle | GO:0033365 | 185 | 0.070 | |
| macromolecule methylation | GO:0043414 | 120 | 0.069 | |
| monosaccharide transport | GO:0015749 | 58 | 0.066 | |
| regulation of protein localization | GO:0032880 | 231 | 0.066 | |
| molting cycle | GO:0042303 | 90 | 0.066 | |
| camera type eye development | GO:0043010 | 266 | 0.065 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.062 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.062 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.061 | |
| membrane lipid biosynthetic process | GO:0046467 | 32 | 0.060 | |
| regulation of cell division | GO:0051302 | 76 | 0.059 | |
| fertilization | GO:0009566 | 127 | 0.057 | |
| response to acid chemical | GO:0001101 | 111 | 0.057 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.057 | |
| intestinal epithelial cell differentiation | GO:0060575 | 14 | 0.055 | |
| carbohydrate transport | GO:0008643 | 62 | 0.055 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.055 | |
| synaptic transmission | GO:0007268 | 329 | 0.054 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.054 | |
| sphingolipid biosynthetic process | GO:0030148 | 26 | 0.053 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.053 | |
| heart morphogenesis | GO:0003007 | 178 | 0.053 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.053 | |
| dna metabolic process | GO:0006259 | 303 | 0.053 | |
| spermatid differentiation | GO:0048515 | 115 | 0.051 | |
| telencephalon development | GO:0021537 | 186 | 0.049 | |
| protein methylation | GO:0006479 | 81 | 0.048 | |
| methylation | GO:0032259 | 134 | 0.048 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.048 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.048 | |
| digestive system development | GO:0055123 | 200 | 0.048 | |
| regulation of ion transport | GO:0043269 | 215 | 0.047 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.047 | |
| gland development | GO:0048732 | 330 | 0.047 | |
| chromatin organization | GO:0006325 | 206 | 0.047 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.047 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.047 | |
| negative regulation of growth | GO:0045926 | 99 | 0.046 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.046 | |
| acid secretion | GO:0046717 | 33 | 0.045 | |
| placenta development | GO:0001890 | 140 | 0.045 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.045 | |
| nuclear division | GO:0000280 | 158 | 0.045 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.045 | |
| detection of external stimulus | GO:0009581 | 61 | 0.044 | |
| hexose transport | GO:0008645 | 56 | 0.044 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.043 | |
| male sex differentiation | GO:0046661 | 109 | 0.043 | |
| intracellular protein transport | GO:0006886 | 204 | 0.042 | |
| histone modification | GO:0016570 | 159 | 0.042 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.042 | |
| limbic system development | GO:0021761 | 72 | 0.042 | |
| chromatin modification | GO:0016568 | 187 | 0.042 | |
| locomotory behavior | GO:0007626 | 195 | 0.042 | |
| regulation of cell activation | GO:0050865 | 289 | 0.041 | |
| lipid localization | GO:0010876 | 126 | 0.041 | |
| spleen development | GO:0048536 | 39 | 0.041 | |
| heart contraction | GO:0060047 | 93 | 0.041 | |
| negative regulation of gastrulation | GO:2000542 | 3 | 0.040 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.040 | |
| regulation of mitosis | GO:0007088 | 29 | 0.040 | |
| glucose transport | GO:0015758 | 56 | 0.040 | |
| maintenance of location | GO:0051235 | 89 | 0.039 | |
| male gonad development | GO:0008584 | 88 | 0.039 | |
| regionalization | GO:0003002 | 337 | 0.039 | |
| female gamete generation | GO:0007292 | 74 | 0.039 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.039 | |
| microtubule based process | GO:0007017 | 236 | 0.039 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.038 | |
| axon guidance | GO:0007411 | 141 | 0.038 | |
| pallium development | GO:0021543 | 120 | 0.038 | |
| synapsis | GO:0007129 | 34 | 0.038 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.038 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.037 | |
| protein targeting | GO:0006605 | 143 | 0.037 | |
| digestion | GO:0007586 | 40 | 0.037 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.037 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.036 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.036 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.036 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.036 | |
| skin development | GO:0043588 | 220 | 0.036 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.036 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.035 | |
| protein alkylation | GO:0008213 | 81 | 0.035 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.035 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.035 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.035 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.035 | |
| stem cell development | GO:0048864 | 219 | 0.034 | |
| histone methylation | GO:0016571 | 71 | 0.034 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.034 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.033 | |
| respiratory tube development | GO:0030323 | 167 | 0.033 | |
| negative regulation of cholesterol efflux | GO:0090370 | 4 | 0.033 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.033 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.033 | |
| gonad development | GO:0008406 | 141 | 0.033 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.033 | |
| neuron projection guidance | GO:0097485 | 141 | 0.033 | |
| regulation of secretion | GO:0051046 | 274 | 0.032 | |
| mrna metabolic process | GO:0016071 | 84 | 0.032 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.032 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.031 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.031 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.031 | |
| regulation of nuclear division | GO:0051783 | 56 | 0.031 | |
| protein catabolic process | GO:0030163 | 221 | 0.031 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.031 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.030 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.030 | |
| ceramide biosynthetic process | GO:0046513 | 20 | 0.030 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.030 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.030 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.030 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.030 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.030 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.029 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.029 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.029 | |
| hypothalamus cell differentiation | GO:0021979 | 8 | 0.029 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.029 | |
| chromosome segregation | GO:0007059 | 48 | 0.029 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.029 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.029 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.029 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.029 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.029 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.028 | |
| heart field specification | GO:0003128 | 6 | 0.028 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.028 | |
| ventral midline development | GO:0007418 | 4 | 0.028 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.027 | |
| negative regulation of cell fate specification | GO:0009996 | 4 | 0.027 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.027 | |
| cell maturation | GO:0048469 | 127 | 0.027 | |
| forebrain development | GO:0030900 | 302 | 0.027 | |
| organelle localization | GO:0051640 | 179 | 0.027 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.027 | |
| negative regulation of wnt signaling pathway involved in heart development | GO:0003308 | 4 | 0.027 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.027 | |
| circulatory system process | GO:0003013 | 197 | 0.027 | |
| sterol homeostasis | GO:0055092 | 45 | 0.027 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.027 | |
| regulation of isoprenoid metabolic process | GO:0019747 | 1 | 0.026 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.026 | |
| exocytosis | GO:0006887 | 121 | 0.026 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.026 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.025 | |
| steroid metabolic process | GO:0008202 | 119 | 0.025 | |
| response to inorganic substance | GO:0010035 | 96 | 0.025 | |
| epithelial cell maturation involved in prostate gland development | GO:0060743 | 4 | 0.025 | |
| calcium ion transport | GO:0006816 | 159 | 0.025 | |
| neurohypophysis development | GO:0021985 | 2 | 0.025 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.024 | |
| vesicle localization | GO:0051648 | 86 | 0.024 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.024 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.024 | |
| cation homeostasis | GO:0055080 | 212 | 0.024 | |
| translation | GO:0006412 | 93 | 0.024 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.024 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.024 | |
| wound healing | GO:0042060 | 157 | 0.024 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.024 | |
| lung development | GO:0030324 | 164 | 0.023 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.023 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.023 | |
| sperm motility | GO:0030317 | 47 | 0.023 | |
| icosanoid secretion | GO:0032309 | 12 | 0.023 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.023 | |
| pigmentation | GO:0043473 | 71 | 0.023 | |
| menarche | GO:0042696 | 1 | 0.023 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.023 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.023 | |
| mesenchyme development | GO:0060485 | 152 | 0.023 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.023 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.022 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.022 | |
| cell fate specification | GO:0001708 | 72 | 0.022 | |
| insulin secretion | GO:0030073 | 89 | 0.022 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.022 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.022 | |
| sensory perception | GO:0007600 | 245 | 0.022 | |
| organelle assembly | GO:0070925 | 177 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.022 | |
| hormone secretion | GO:0046879 | 128 | 0.022 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.022 | |
| regulation of vitamin metabolic process | GO:0030656 | 3 | 0.021 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.021 | |
| kidney development | GO:0001822 | 213 | 0.021 | |
| mapk cascade | GO:0000165 | 281 | 0.021 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.021 | |
| oocyte maturation | GO:0001556 | 18 | 0.021 | |
| cardiac cell fate determination | GO:0060913 | 2 | 0.021 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.021 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.021 | |
| endomembrane system organization | GO:0010256 | 147 | 0.021 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.021 | |
| positive regulation of vasoconstriction | GO:0045907 | 4 | 0.021 | |
| ectoderm formation | GO:0001705 | 3 | 0.020 | |
| mitotic nuclear division | GO:0007067 | 48 | 0.020 | |
| lipid storage | GO:0019915 | 36 | 0.020 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.020 | |
| peptide transport | GO:0015833 | 133 | 0.020 | |
| tissue remodeling | GO:0048771 | 102 | 0.020 | |
| rna processing | GO:0006396 | 105 | 0.020 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.020 | |
| regulation of translation | GO:0006417 | 71 | 0.020 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.020 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | |
| left lung development | GO:0060459 | 4 | 0.020 | |
| mesoderm formation | GO:0001707 | 62 | 0.020 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.020 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.019 | |
| regulation of heart induction by regulation of canonical wnt signaling pathway | GO:0090081 | 2 | 0.019 | |
| mating behavior sex discrimination | GO:0048047 | 1 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.019 | |
| spermatid development | GO:0007286 | 108 | 0.019 | |
| anion transport | GO:0006820 | 177 | 0.019 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.019 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.019 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.019 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.019 | |
| regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry | GO:1900094 | 2 | 0.019 | |
| apoptotic process involved in outflow tract morphogenesis | GO:0003275 | 2 | 0.019 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.019 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.019 | |
| ovarian follicle development | GO:0001541 | 40 | 0.019 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.019 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.018 | |
| endoderm formation | GO:0001706 | 20 | 0.018 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.018 | |
| cell differentiation involved in kidney development | GO:0061005 | 33 | 0.018 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.018 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.018 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.018 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.018 | |
| cellular homeostasis | GO:0019725 | 240 | 0.018 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.018 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.018 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.018 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.018 | |
| single fertilization | GO:0007338 | 82 | 0.017 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.017 | |
| plasma membrane organization | GO:0007009 | 90 | 0.017 | |
| oocyte development | GO:0048599 | 33 | 0.017 | |
| tube formation | GO:0035148 | 140 | 0.017 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.017 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.017 | |
| respiratory system development | GO:0060541 | 190 | 0.017 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.017 | |
| renal sodium excretion | GO:0035812 | 3 | 0.017 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.017 | |
| regulation of histone modification | GO:0031056 | 56 | 0.017 | |
| protein import into nucleus | GO:0006606 | 95 | 0.017 | |
| nuclear transport | GO:0051169 | 139 | 0.017 | |
| hair cycle | GO:0042633 | 90 | 0.017 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.017 | |
| cellular response to carbohydrate stimulus | GO:0071322 | 50 | 0.017 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.017 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.017 | |
| cerebral cortex development | GO:0021987 | 86 | 0.017 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.017 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.017 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.017 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.017 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.017 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.016 | |
| amine metabolic process | GO:0009308 | 45 | 0.016 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.016 | |
| negative regulation of mesodermal cell fate specification | GO:0042662 | 3 | 0.016 | |
| regulation of cell migration | GO:0030334 | 219 | 0.016 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.016 | |
| transmembrane transport | GO:0055085 | 412 | 0.016 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.016 | |
| cerebral cortex radially oriented cell migration | GO:0021799 | 31 | 0.016 | |
| stem cell maintenance | GO:0019827 | 130 | 0.016 | |
| regulation of transcription involved in cell fate commitment | GO:0060850 | 15 | 0.016 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.016 | |
| adult behavior | GO:0030534 | 135 | 0.016 | |
| primary prostatic bud elongation | GO:0060516 | 2 | 0.016 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.016 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.016 | |
| dendrite development | GO:0016358 | 115 | 0.016 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.016 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.016 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.016 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.016 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.015 | |
| endoderm development | GO:0007492 | 45 | 0.015 | |
| cytokine production | GO:0001816 | 319 | 0.015 | |
| lung cell differentiation | GO:0060479 | 30 | 0.015 | |
| hypothalamus development | GO:0021854 | 16 | 0.015 | |
| renal system development | GO:0072001 | 225 | 0.015 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.015 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.015 | |
| tube closure | GO:0060606 | 91 | 0.015 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.015 | |
| positive regulation of cellular protein catabolic process | GO:1903364 | 34 | 0.015 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.015 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.015 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.015 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.015 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.015 | |
| membrane organization | GO:0061024 | 245 | 0.015 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.015 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.015 | |
| heart process | GO:0003015 | 94 | 0.015 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.015 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.015 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.015 | |
| dephosphorylation | GO:0016311 | 129 | 0.015 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.015 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.015 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.015 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.015 | |
| tissue homeostasis | GO:0001894 | 115 | 0.014 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.014 | |
| cytokinetic process | GO:0032506 | 2 | 0.014 | |
| regulation of protein localization to nucleus | GO:1900180 | 60 | 0.014 | |
| response to light stimulus | GO:0009416 | 135 | 0.014 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.014 | |
| epithelial mesenchymal signaling involved in prostate gland development | GO:0060738 | 2 | 0.014 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.014 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.014 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.014 | |
| peptide secretion | GO:0002790 | 114 | 0.014 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.014 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.014 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.014 | |
| response to amino acid | GO:0043200 | 37 | 0.014 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.014 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.014 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.014 | |
| skeletal system development | GO:0001501 | 356 | 0.014 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.014 | |
| ear development | GO:0043583 | 200 | 0.014 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.014 | |
| thick ascending limb development | GO:0072023 | 2 | 0.014 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.014 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.014 | |
| long chain fatty acid transport | GO:0015909 | 15 | 0.014 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.014 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.014 | |
| cellular response to lipid | GO:0071396 | 145 | 0.014 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.014 | |
| prostate gland morphogenetic growth | GO:0060737 | 4 | 0.014 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.014 | |
| limb development | GO:0060173 | 166 | 0.014 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.014 | |
| segmentation | GO:0035282 | 93 | 0.013 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.013 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.013 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.013 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.013 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.013 | |
| mitral valve development | GO:0003174 | 4 | 0.013 | |
| muscle system process | GO:0003012 | 141 | 0.013 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.013 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.013 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.013 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.013 | |
| metanephric thick ascending limb development | GO:0072233 | 2 | 0.013 | |
| cell growth | GO:0016049 | 130 | 0.013 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.013 | |
| regulation of exocytosis | GO:0017157 | 61 | 0.013 | |
| fibroblast growth factor receptor signaling pathway | GO:0008543 | 46 | 0.013 | |
| regulation of monocyte extravasation | GO:2000437 | 2 | 0.013 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.013 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.012 | |
| regulation of endodermal cell fate specification | GO:0042663 | 2 | 0.012 | |
| pulmonary myocardium development | GO:0003350 | 3 | 0.012 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.012 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.012 | |
| ascending thin limb development | GO:0072021 | 2 | 0.012 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.012 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.012 | |
| cardiac conduction | GO:0061337 | 17 | 0.012 | |
| sodium ion transport | GO:0006814 | 73 | 0.012 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.012 | |
| cardiac chamber development | GO:0003205 | 108 | 0.012 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.012 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.012 | |
| oocyte axis specification | GO:0007309 | 2 | 0.012 | |
| intermediate filament cytoskeleton organization | GO:0045104 | 26 | 0.012 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.012 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.012 | |
| reproductive behavior | GO:0019098 | 32 | 0.012 | |
| mitotic cytokinesis | GO:0000281 | 4 | 0.012 | |
| neural tube formation | GO:0001841 | 108 | 0.012 | |
| positive regulation of transcription from rna polymerase iii promoter | GO:0045945 | 1 | 0.012 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.012 | |
| epithalamus development | GO:0021538 | 2 | 0.012 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.012 | |
| positive regulation of reproductive process | GO:2000243 | 19 | 0.012 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.012 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.012 | |
| inner cell mass cell fate commitment | GO:0001827 | 2 | 0.012 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.012 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.012 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.012 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.012 | |
| male genitalia morphogenesis | GO:0048808 | 4 | 0.012 | |
| spinal cord ventral commissure morphogenesis | GO:0021965 | 2 | 0.012 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.012 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.012 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.012 | |
| neuron fate specification | GO:0048665 | 30 | 0.012 | |
| detection of abiotic stimulus | GO:0009582 | 60 | 0.012 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.012 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.012 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.012 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.012 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.012 | |
| epithelial tube formation | GO:0072175 | 130 | 0.012 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.012 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.011 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.011 | |
| mesoderm development | GO:0007498 | 100 | 0.011 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.011 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.011 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.011 | |
| neuronal action potential | GO:0019228 | 54 | 0.011 | |
| muscle contraction | GO:0006936 | 101 | 0.011 | |
| type b pancreatic cell fate commitment | GO:0003327 | 1 | 0.011 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.011 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.011 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.011 | |
| substantia nigra development | GO:0021762 | 2 | 0.011 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.011 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.011 | |
| determination of left right asymmetry in nervous system | GO:0035545 | 1 | 0.011 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.011 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.011 | |
| female sex differentiation | GO:0046660 | 84 | 0.011 | |
| odontogenesis | GO:0042476 | 78 | 0.011 | |
| female somatic sex determination | GO:0019101 | 1 | 0.011 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.011 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.011 | |
| regulation of transcription from rna polymerase iii promoter | GO:0006359 | 2 | 0.011 | |
| heart induction | GO:0003129 | 2 | 0.011 | |
| lung epithelial cell differentiation | GO:0060487 | 29 | 0.011 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.011 | |
| negative regulation of cell division | GO:0051782 | 24 | 0.011 | |
| regulation of erythrocyte differentiation | GO:0045646 | 23 | 0.011 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.011 | |